Neutral Air Partner (NAP) has launched a specialist community for freight forwarders and air cargo partners active in pharmaceutical, healthcare and life sciences logistics.
NAP Pharma has been created to support independent air cargo specialists in areas including quality, training, compliance, visibility and trusted partnerships in a wider bid to ensure safe and reliable supply chains.
The community brings together pharma-certified SME forwarders, cold chain specialists, packaging providers, technology companies, compliance experts and life sciences logistics professionals within the NAP ecosystem.
The initiative builds on NAP’s partnership with Pharma.Aero, an international cross-industry collaboration platform dedicated to advancing logistics in the life science and medtech industries
After more than four years of cooperation, NAP and Pharma.Aero are expanding their work together through education, knowledge sharing, specialist industry engagement and access to recognised pharma logistics expertise.
The new vertical was officially introduced at NAP’s 10th AGM, OPENAP10, in Marrakech last month.
NAP Pharma is also supported by a new collaboration with 4Viso, a compliance and risk intelligence platform for pharmaceutical logistics.
The collaboration focuses on audit readiness, risk visibility and structured partner intelligence.
Christos Spyrou, founder and chief executive of Neutral Air Partner, commented: “Pharma and life sciences logistics is a sector where quality, training, compliance and trust are essential.
“Through our strategic partnership with Pharma.Aero, and with the compliance intelligence support of 4Viso, we are creating a focused platform that helps our members build the right capabilities, connect with recognised experts and grow in this important global market.”
Frank Van Gelder, secretary general of Pharma.Aero, commented: “Education, knowledge sharing and cross-industry collaboration are essential to improving the quality and resilience of life sciences supply chains.
“By engaging NAP’s global community of independent air cargo specialists, we see a valuable opportunity to support forwarders who are committed to advancing their pharma logistics expertise.”
